About: Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $33.05 (+0.30%)
NBTX NASDAQ Nanobiotix
Nanobiotix share price
Atividade de preço de NBTX
Último preço
$ 33,050
Variação (24h)
0,10 USD (0,30%)
Volume
104.39K
Volume (média 4 sem.)
-
Abertura
$ 31,94
Variação do dia
$ 31,28 - $ 33,35
Fechamento anterior
$ 32,95
Último negócio
12 Nov, 7:58 pm GMT+0
Atrasado
12 Nov, 7:58 pm GMT+0
NBTX price performance
Atrasado
12 Nov, 7:58 pm GMT+0
NBTX details
quote.marketSignals